Literature DB >> 11928823

Role of myofibroblasts at the invasion front.

Olivier De Wever1, Marc Mareel.   

Abstract

Tumor progression occurs within a microecosystem, where cancer cells and myofibroblasts exchange proteinases and cytokines that promote growth directly through stimulation of proliferation and survival, as well as invasion through local proteolysis of the extracellular matrix and stimulation of motility. Myofibroblasts maintain the capacity of fibroblasts to induce differentiation. Fibroblasts are the main source of tumor-associated myofibroblasts. The transition to myofibroblasts also occurs in noncancerous situations. This transition is modulated by mechanical stress and cytokines, amongst which transforming growth factor-beta. The cross-talk between cancer cells and myofibroblasts illustrates the microecosystem of tumor invasion. In order to consider myofibroblasts as a possibly new target for cancer therapy, further characterization of the molecular cross-talk between myofibroblasts and cancer cells is required.

Entities:  

Mesh:

Year:  2002        PMID: 11928823     DOI: 10.1515/BC.2002.006

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  22 in total

1.  Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer.

Authors:  Ya-Qiang Huang; Zhao-Dong Han; Yu-Xiang Liang; Zhuo-Yuan Lin; Xiao-Hui Ling; Xin Fu; Chao Cai; Xue-Cheng Bi; Qi-Shan Dai; Jia-Hong Chen; Hui-Chan He; Yan-Ru Chen; Fu-Neng Jiang; Wei-de Zhong
Journal:  Med Oncol       Date:  2013-12-14       Impact factor: 3.064

2.  Comparison of myofibroblasts expression in oral squamous cell carcinoma, verrucous carcinoma, high risk epithelial dysplasia, low risk epithelial dysplasia and normal oral mucosa.

Authors:  Minal Chaudhary; Amol Ramchandra Gadbail; Gaurav Vidhale; Mugdha P Mankar Gadbail; Shailesh M Gondivkar; Madhuri Gawande; Swati Patil
Journal:  Head Neck Pathol       Date:  2012-03-06

3.  Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells.

Authors:  Julia Schulte; Michaela Weidig; Philipp Balzer; Petra Richter; Marcus Franz; Kerstin Junker; Mieczyslaw Gajda; Karlheinz Friedrich; Heiko Wunderlich; Arne Östman; Iver Petersen; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2012-07-22       Impact factor: 4.304

4.  Nucleolar organizing regions and alpha-smooth muscle actin expression in a case of ameloblastic carcinoma.

Authors:  Kavitha P Kamath; M Vidya; Nandaprasad Shetty; Bhavana V Karkera; Hemanth Jogi
Journal:  Head Neck Pathol       Date:  2010-03-24

5.  EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.

Authors:  Xianglan Zhang; Im-Hee Jung; Young Sun Hwang
Journal:  Tumour Biol       Date:  2015-09-19

Review 6.  Soluble cadherins as cancer biomarkers.

Authors:  Olivier De Wever; Lara Derycke; An Hendrix; Gert De Meerleer; François Godeau; Herman Depypere; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

7.  Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture.

Authors:  Alicia B Moore; Linda Yu; Carol D Swartz; Xaiolin Zheng; Lu Wang; Lysandra Castro; Grace E Kissling; David K Walmer; Stanley J Robboy; Darlene Dixon
Journal:  Cell Commun Signal       Date:  2010-06-10       Impact factor: 5.712

Review 8.  Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics.

Authors:  Elly De Vlieghere; Laurine Verset; Pieter Demetter; Marc Bracke; Olivier De Wever
Journal:  Virchows Arch       Date:  2015-08-11       Impact factor: 4.064

9.  The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.

Authors:  Birgitte Vrou Offersen; Boye Schnack Nielsen; Gunilla Høyer-Hansen; Fritz Rank; Stephen Hamilton-Dutoit; Jens Overgaard; Peter A Andreasen
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?

Authors:  Olga Genin; Gideon Rechavi; Arnon Nagler; Ofer Ben-Itzhak; Kellie J Nazemi; Mark Pines
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.